Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside

Immune checkpoint inhibitor (ICI)-related inflammatory diseases, including polymyositis (PM) and dermatomyositis (DM), in patients suffering from neoplastic disorders represent a medical challenge. The treatment of these conditions has taken on new urgency due to the successful and broad development...

Descripción completa

Detalles Bibliográficos
Autores principales: Solimando, Antonio G., Crudele, Lucilla, Leone, Patrizia, Argentiero, Antonella, Guarascio, Matteo, Silvestris, Nicola, Vacca, Angelo, Racanelli, Vito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246673/
https://www.ncbi.nlm.nih.gov/pubmed/32357515
http://dx.doi.org/10.3390/ijms21093054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246673/
https://www.ncbi.nlm.nih.gov/pubmed/32357515
http://dx.doi.org/10.3390/ijms21093054

Ejemplares similares